For patients with NSCLC, the following molecular alterations were reported: RET alterations in 24 patients, MET alterations in 12 patients, CBL alterations in ten patients, Chr4q12 amplification in four patients and AXL, KDR and NTRK alterations in one patient each. This evidence concerns the gene RET and non-small cell lung carcinoma.